Search

Your search keyword '"Bollineni, Srinivas"' showing total 190 results
Start Over Author "Bollineni, Srinivas"
190 results on '"Bollineni, Srinivas"'

6. Effects of Extracorporeal Membrane Oxygenation Initiation on Oxygenation and Pulmonary Opacities

Author

Batra Kiran, Mohanka Manish, Bollineni Srinivas, Kaza Vaidehi, Rajiah Prabhakar, Xi Yin, Hackmann Amy, Wait Michael, Torres Fernando, and Banga Amit

Subjects
ecmo, acute lung injury, cytokine surge, refractory hypoxia, systemic inflammatory response, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9
Abstract

There is limited data on the impact of extracorporeal membrane oxygenation (ECMO) on pulmonary physiology and imaging in adult patients. The current study sought to evaluate the serial changes in oxygenation and pulmonary opacities after ECMO initiation.

Published
2021
Full Text
View/download PDF

8. Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients

Author

Narasimhan, Madhusudhanan, primary, Muthukumar, Alagarraju, additional, Sataranatarajan, Kavithalakshmi, additional, Mahimainathan, Lenin, additional, Mahan, Luke, additional, Timofte, Irina, additional, Bollineni, Srinivas, additional, Joerns, John, additional, Zhang, Song, additional, Gorman, April, additional, Banga, Amit, additional, Mohanka, Manish, additional, Torres, Fernando, additional, Lawrence, Adrian, additional, Thalachallour, Mohanakumar, additional, and Kaza, Vaidehi, additional

Published
2023
Full Text
View/download PDF

9. IMPROVED POST-COVID INTERSTITIAL LUNG DISEASE OUTCOMES USING A NOVEL THERAPEUTIC REGIMEN

Author

TIMOFTE, IRINA L, primary, SHEDD, CHRISTINE, additional, GARCIA, BRISA, additional, ISHAQ, ARIANA, additional, RYAN, ALICE, additional, KAZA, VAIDEHI, additional, BOLLINENI, SRINIVAS, additional, JOERNS, JOHN O, additional, LAWRENCE, ADRIAN C, additional, MAHAN, LUKE D, additional, BANGA, AMIT, additional, MOHANKA, MANISH R, additional, TERADA, LANCE, additional, and TORRES, FERNANDO, additional

Published
2023
Full Text
View/download PDF

10. COMPARATIVE OUTCOMES AMONG LUNG TRANSPLANT PATIENTS WITH COVID-19 FROM OMICRON AND NON-OMICRON VARIANTS

Author

ROSE, JOHN, primary, MAHAN, LUKE D, additional, MOHANKA, MANISH R, additional, LAWRENCE, ADRIAN C, additional, JOERNS, JOHN O, additional, BOLLINENI, SRINIVAS, additional, KAZA, VAIDEHI, additional, TIMOFTE, IRINA L, additional, SORELLE, JEFFREY, additional, KERSHAW, COREY, additional, TERADA, LANCE, additional, TORRES, FERNANDO, additional, and BANGA, AMIT, additional

Published
2023
Full Text
View/download PDF

11. TELEMEDICINE PATIENT SATISFACTION WITH VIRTUAL TRANSPLANT CLINIC

Author

JOERNS, JOHN O, primary, VILLALONGA OLIVES, ESTER, additional, MAHAN, LUKE D, additional, KIM, JUNE, additional, KAZA, VAIDEHI, additional, BOLLINENI, SRINIVAS, additional, MOHANKA, MANISH R, additional, LAWRENCE, ADRIAN C, additional, VARGHESE, ANU, additional, IACONO, ALDO, additional, PELTZ, MATTHIAS, additional, HUFFMAN, LYNN, additional, TORRES, FERNANDO, additional, WAIT, MICHAEL A, additional, and TIMOFTE, IRINA L, additional

Published
2023
Full Text
View/download PDF

13. NEUROMUSCULAR ELECTRICAL STIMULATION IN ADDITION TO PHYSICAL THERAPY PREVENTS MUSCLE ATROPHY AFTER LUNG TRANSPLANT SURGERY

Author

LAWRENCE, ADRIAN C, primary, MAHAN, LUKE D, additional, KAZA, VAIDEHI, additional, RYAN, ALICE, additional, BOLLINENI, SRINIVAS, additional, MOHANKA, MANISH R, additional, JOERNS, JOHN O, additional, WAIT, MICHAEL A, additional, PELTZ, MATTHIAS, additional, HUFFMAN, LYNN, additional, VERCELES, AVELINO, additional, VARGHESE, ANU, additional, WELLS, CHRIS, additional, IACONO, ALDO, additional, TORRES, FERNANDO, additional, TERRIN, MICHAEL L, additional, MAGDER, LARRY, additional, and TIMOFTE, IRINA L, additional

Published
2023
Full Text
View/download PDF

21. ECMO Long Haulers: A Distinct Phenotype of COVID-19–Associated ARDS With Implications for Lung Transplant Candidacy

Author

Mohanka, Manish R., primary, Joerns, John, additional, Lawrence, Adrian, additional, Bollineni, Srinivas, additional, Kaza, Vaidehi, additional, Cheruku, Sreekanth, additional, Leveno, Matthew, additional, Chen, Catherine, additional, Terada, Lance S., additional, Kershaw, Corey D., additional, Torres, Fernando, additional, Peltz, Matthias, additional, Wait, Michael A., additional, Hackmann, Amy E., additional, and Banga, Amit, additional

Published
2022
Full Text
View/download PDF

22. Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID‐19

Author

Bollineni, Srinivas, primary, Mahan, Luke D., additional, Duncan, Patrick, additional, Mohanka, Manish R., additional, Lawrence, Adrian, additional, Joerns, John, additional, Timofte, Irina, additional, Torres, Fernando, additional, La Hoz, Ricardo M., additional, Kershaw, Corey D., additional, Terada, Lance S., additional, Kaza, Vaidehi, additional, and Banga, Amit, additional

Published
2022
Full Text
View/download PDF

24. Post‐infection pulmonary sequelae after COVID‐19 among patients with lung transplantation

Author

Mahan, Luke D., primary, Lill, Isaac, additional, Halverson, Quinn, additional, Mohanka, Manish R., additional, Lawrence, Adrian, additional, Joerns, John, additional, Bollineni, Srinivas, additional, Kaza, Vaidehi, additional, La Hoz, Ricardo M., additional, Zhang, Song, additional, Kershaw, Corey D., additional, Terada, Lance S., additional, Torres, Fernando, additional, and Banga, Amit, additional

Published
2021
Full Text
View/download PDF

28. Predictors and outcomes of respiratory failure among lung transplant patients with COVID‐19.

Author

Lawrence, Adrian, Mahan, Luke D., Mohanka, Manish R., Bollineni, Srinivas, Kaza, Vaidehi, La Hoz, Ricardo M., Zhang, Song, Kershaw, Corey D., Terada, Lance S., Torres, Fernando, and Banga, Amit

Subjects
COVID-19, LUNG transplantation, RESPIRATORY insufficiency, CORONAVIRUS diseases, BODY mass index, ARTIFICIAL respiration
Abstract

Background: There is limited data on the predictors and outcomes of new or worsening respiratory failure among lung transplant (LT) patients with Coronavirus disease 2019 (COVID‐19). Methods: We included all the LT patients diagnosed with COVID‐19 during a 1‐year period (March 2020 to February 2021; n = 54; median age: 60, 20–73 years; M:F 37:17). Development of new or worsening respiratory failure (ARF) was the primary outcome variable. Results: The overall incidence of ARF was 48.1% (n = 26). More than 20% of patients (n = 11) needed intubation and mechanical ventilation. Body mass index > 25 Kg/m2 (adjusted OR: 5.7,.99–32.93; P =.05) and peak D‐dimer levels >.95 mcg/ml (adjusted OR: 24.99, 1.77–353.8; P =.017) were independently associated with ARF while anticoagulation use prior to COVID‐19 was protective (adjusted OR:.024,.001–.55; P =.02). Majority patients survived the acute illness (85.2%). Pre‐infection chronic lung allograft dysfunction (CLAD) was an independent predictor of mortality (adjusted HR: 5.03, 1.14–22.25; P =.033). Conclusions: COVID‐19 is associated with significant morbidity and mortality among LT patients. Patients on chronic anticoagulation seem to enjoy favorable outcomes, while higher BMI and peak D‐dimer levels are associated with development of ARF. Pre‐infection CLAD is associated with an increased risk of death from COVID‐19. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

34. Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection.

Author

Mahan, Luke D., Points, April, Mohanka, Manish R., Bollineni, Srinivas, Joerns, John, Kaza, Vaidehi, La Hoz, Ricardo M., Gao, Ang, Zhang, Song, Torres, Fernando, and Banga, Amit

Subjects
RESPIRATORY syncytial virus infections, VITAL capacity (Respiration), LUNG transplantation, FORCED expiratory volume, PROPENSITY score matching
Abstract

Background: To describe characteristics and outcomes among lung transplantation (LT) patients with respiratory syncytial virus (RSV) infection and elucidate the predictors of 1‐year survival after RSV infection. Methods: This was a retrospective chart review study among LT patients with RSV infection between 2013 and 2018 (90 episodes among 87 patients; mean age 56.3 ± 13.1 years, M:F 52:35). A contemporaneous control group consisting of LT patients without RSV infection (n = 183) was included. One‐year survival after the RSV infection was the primary endpoint. Results: Median time from LT to RSV infection was 30 (1‐155) months. Before RSV infection, the median decline in forced vital capacity (FVC) was 9.7 cc (−17.8 to 83 cc) or 0.29% (−1.4% to 4.6%) per month, while the forced expiratory volume (FEV1) decline was 7.5 cc (−8.8 to 58 cc) or 0.3% (−0.57% to 4.3%) per month with no statistically significant change after RSV infection. One‐year survival among patients with RSV infection was 86.2% (75/87). Pre‐infection diagnosis of chronic lung allograft dysfunction (CLAD; adjusted HR: 4.29, 1.08‐17.0; P =.038) and FVC or FEV1 decline >10% during 6 months post infection (adjusted HR: 35.1, 3.26‐377.1; P =.003) were independently associated with worse survival. On propensity score matched analysis, RSV infection was not associated with worse post‐transplant survival (HR with 95% CI: 0.79, 0.47‐1.34; P =.38). Conclusions: A majority of LT patients in the current cohort did not experience an alteration in the trajectory of FVC or FEV1 decline after developing RSV infection, and their post‐transplant survival was not adversely impacted. Established CLAD at the time of RSV infection and post infection >10% decline in FVC or FEV1 are independently associated with worse survival after RSV infection. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

38. Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit

Author

Kamity Ranjit, Sharma Surendra K, Rao Mangu H, Reddy Lebaka, Premanand Raya, Mohan Alladi, and Bollineni Srinivas

Subjects
Diseases of the respiratory system, RC705-779
Abstract

Abstract Background Severe acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) is a common reason for emergency room (ER) visit about which little has been documented from India. Methods Prospective study of the clinical presentation and predictors of outcome in 116 patients presenting with severe AE-COPD requiring admission to the medical intensive care unit between January 2000 and December 2004. Results Their mean age was 62.1 ± 9.8 years. There were 102 males. Mean duration of COPD was 7.2 ± 5.8 years. All males were smokers (22.3 ± 11.2 pack years); 35.2% smoked cigarettes and 64.8% smoked bidis. All women were exposed to domestic fuel. Associated co-morbid illnesses were present in 81 patients (69.8%); 53(45.7%) had one co-morbid illness and the remaining 28 (54.3%) had two or more co-morbid illnesses. Evidence of past pulmonary tuberculosis (PTB) was present in 28.4% patients; 5 patients who also had type II diabetes mellitus had active PTB. Arterial blood gas analysis revealed respiratory failure in 40 (33.8%) patients (type I 17.5% and type II 82.5%). Invasive mechanical ventilation was required in 18 patients. Sixteen (13.7%) patients died. Stepwise multivariate logistic regression analysis revealed need for invasive ventilation (OR 45.809, 95%CI 607.46 to 3.009;p < 0.001); presence of co-morbid illness (OR 0.126, 95%CI 0.428 to 0.037;p < 0.01) and hypercapnia (OR 0.114, 95%CI 1.324 to 0.010;p < 0.05) were predictors of death. Conclusion Co-morbid conditions and metabolic abnormalities render the diagnosis of AE-COPD difficult and also contribute to mortality. High prevalence of past PTB and active PTB in patients with AE-COPD suggests an intriguing relationship between smoking, PTB and COPD which merits further study.

Published
2006
Full Text
View/download PDF

39. Characteristics and outcomes among patients with community‐acquired respiratory virus infections during the first year after lung transplantation.

Author

Mahan, Luke D., Kanade, Rohan, Mohanka, Manish R., Bollineni, Srinivas, Joerns, John, Kaza, Vaidehi, Torres, Fernando, La Hoz, Ricardo M., and Banga, Amit

Subjects
RESPIRATORY infections, VIRUS diseases, LUNG transplantation, COMMUNITY-acquired infections, DIAGNOSIS
Abstract

Background: The current study describes the spectrum of community‐acquired respiratory infections (CARV) during the first year after lung transplantation (LT). Additionally, we elucidate variables associated with CARV, management strategies utilized, and impact on early and late outcomes. Methods: This was a retrospective study among patients transplanted between 2012 and 2015 (n = 255, mean age 55.6 ± 13.5 years, M: F 152:103). The diagnosis of CARV was based on the multiplex PCR on nasopharyngeal swab samples. Baseline characteristics, post‐transplant variables, and outcomes were compared among patients with and without CARV. Results: Eighty CARV infections developed among a quarter of the study group (n = 62, 24.3%). Rhinovirus/enterovirus was the most commonly isolated CARV (n = 24) followed by coronavirus (n = 17) and RSV (n = 9). A significant proportion of episodes (43.8%) required hospitalization. The use of nasal corticosteroids and left single LT was independently associated with an increased risk of CARV. CARV infections did not impact the lung functions during the first year or the CLAD‐free survival at 3 years. Conclusions: There is a significant burden of CARV infections during the first year after LT. The use of nasal corticosteroids may increase the risk of CARV infection. CARV infections did not impact outcomes. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

40. Insult to Injury: Development of Alveolar Hemorrhage after Initiation of Extracorporeal Membrane Oxygenation.

Author

Williams, Sarah, Batra, Kiran, Mohanka, Manish, Bollineni, Srinivas, Kaza, Vaidehi, Torres, Fernando, and Banga, Amit

Subjects
LUNG injuries, STEROIDS, EXTRACORPOREAL membrane oxygenation, COMPARATIVE studies, HEMORRHAGE, ACUTE diseases
Abstract

Background: Extracorporeal membrane oxygenation (ECMO) is associated with complications that are separate from the underlying diagnoses that require its use. One of the foremost complications of ECMO is a high incidence of bleeding, including alveolar hemorrhage (AH), which is believed to be due to both prophylactic anticoagulation and critical illness-induced systemic coagulopathy. However, akin to systemic inflammatory response syndrome after cardiopulmonary bypass, ECMO causes widespread systemic inflammation and acute lung injury, which likely further predisposes patients to AH. The burden of clinically significant AH among patients on ECMO for advanced lung disease remains unknown. Patients and methods: Charts of patients with advanced lung disease who required ECMO at a single institution were reviewed. The clinical course and variables of patients who developed AH and those who did not were compared. Results: This report describes five patients who developed AH after initiation of venovenous ECMO for refractory hypoxemia. Clinical and laboratory variables did not predict the development or the prognosis of AH. Two of these patients with refractory hypoxemia and AH were treated with pulse-dose corticosteroids, with a dramatic response in one case. Conclusion: The acute decompensation of the patients and response to corticosteroids suggest AH was mediated by a systemic inflammatory process, as opposed to coagulopathy alone. Judicious use of steroids may be considered among select patients who develop AH without symptoms of systemic coagulopathy after initiation of ECMO. [ABSTRACT FROM AUTHOR]

Published
2020

43. Evaluation of current strategies for surveillance and management of donor-specific antibodies: Single-center study

Author

Sullivan, Daniel, primary, Ahn, Chul, additional, Gao, Ang, additional, Lacelle, Chantale, additional, Torres, Fernando, additional, Bollineni, Srinivas, additional, Banga, Amit, additional, Mullins, Jessica, additional, Mohanka, Manish, additional, Ring, Steve, additional, Wait, Michael, additional, Peltz, Matthias, additional, Duddupudi, Pavan, additional, Surapaneni, Dhiraj, additional, and Kaza, Vaidehi, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results